期刊文献+

血浆N-末端脑钠肽前体水平与急性冠状动脉综合征严重程度的关系 被引量:7

Plasm N-terminal pro-B-type natriaretic peptide (NT-proBNP) levels and severity of coronary artery lesions in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨血浆N末端脑钠肽前体(NT-proBNP)水平与急性冠状动脉综合征(ACS)及冠状动脉病变严重程度的关系。方法对150例胸痛患者行选择性冠状动脉造影,其中ACS78例(ACS组),稳定性心绞痛(SA)33例(SA组),冠状动脉造影正常39例(正常对照组)。采用Gensini积分法评价冠状动脉病变的严重程度,同时测定患者血浆NT-proBNP水平和左室射血分数(LVEF),分析血浆NT-proBNP水平与冠心病临床严重程度及冠状动脉造影Gensini积分之间的关系。结果ACS组患者血浆NT-proBNP水平明显高于SA组和正常对照组(P<0.05)。ACS组患者血浆NT-proBNP水平与冠状动脉造影Gensini积分呈正相关(r=0.8534,P=0.0001),与LVEF呈负相关(r=0.5500,P=0.0001)。结论血浆NT-proBNP水平可反映ACS患者冠状动脉病变的严重程度。 Objective To investigate the relationship between plasm N-terminal pro-B-type natriuretic peptide(NT-proBNP) levels and severity of coronary artery disease and coronary artery lesions. Methods 150 patients complaining of chest pain and suspected to have coronary artery disease (CAD) were enrolled in the study. Plasm NT-proBNP contents were determined with ELISA method within 48h, and left ventricular ejection fraction (LVEF) was assessed with echocardiography 5-7 days after admission. All patients underwent coronary artery angiography(CAG) 2-17 days after admission and the severity of coronary artery lesions was estimated by coronary angiographic Gensini scores. According to the clinical data and results of CAG, 78 patients were diagnosed as acute coronary syndromes (ACS), 33 patients as stable angina, and 39 patients in whom angiography showed negative findings, served as normal controls. The correlation of plasm NT-proBNP levels with clinical severity of coronary artery disease and Gensini scores were analysed. Results Plasm NT-proBNP levels in patients with ACS, stable angina and in normal controlls were 526. 96±376. 90, 95. 61±56. 32 and 41. 75±24. 26pg/ml,respectively(P〈0. 05). The Gensini Scores of CAG in patients with ACS, stable angina and in normal controlls were 44. 52±29. 10, 9. 27±2.96 and 0,respectively (P〈0. 01). Plasm NT-ProBNP levels in patients with left main cronary disease was increased compared with that in patients with 1, 2, or 3 coronary vessels disease Plasm NT-ProBNP levels were positively correlated with the Gensini Scores of CAG in all patients (P=0. 0001) and negatively correlated with LVEF in patients with ACS (P=0. 0001). Conclusion Plasm NT-proBNP levels is correlated with the clinical severity of CAD and angiogmphic cornary artery lensions in patients with ACS, therefore it can be used as a biochemical marker for risk stratification in patients with CAD.
机构地区 解放军第
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第11期1171-1173,共3页 Medical Journal of Chinese People's Liberation Army
关键词 冠状动脉综合征 急性 利钠肽 冠状血管造影术 左室射血分数 coronary syndromes, acute natriuretic peptide, brain coronary angiography left ventricular ejection fraction
  • 相关文献

参考文献6

  • 1Jernberg T,Stridsberg M,Venge P,et al.N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.J Am Coll Cardiol,2002,40(3):437.
  • 2曹雅旻,胡大一,闫丽.急性冠状动脉综合征严重程度与血浆氨基酸N末端脑钠肽原浓度相关性的研究[J].中华心血管病杂志,2005,33(10):899-902. 被引量:60
  • 3Estrada JLN,Rubinstein F,Bahit MC,et al.NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes.Am Heart J,2006,15(15):1093.
  • 4Lindahl B,Lindback J,Jernberg T,et al.Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with no-ST-segment elevation acute coronary syndromes:a Fragmin and fast Revascularisation during In Stability in Coronary artery disease(FRISC)-Ⅱ substudy.J Am Coll Cardiol,2005,45(4):533.
  • 5Ndrepepa G,Braun S,Mehilli J,et al.Plasma levels of N-termial pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation,angiographic severity,and left ventricular ejection fraction.Am J Cardiol,2005,95(5):553.
  • 6Hong SN,Yoon NS,Ahn Y,et al.N-terminal pro-B-type natriuretic peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram,echocardigram and cardiac enzymes.Circ J,2005,69(12):1472.

二级参考文献17

  • 1Cheung BMY, Kumana CR. Nariuretic peptides-relevance in cardiac disease. JAMA, 1998,280:1983-1984.
  • 2Etsuo M, Hirofumi Y, Michihiro Y, et al. Increased plamsma levels of brain natriuritic peptide in patients with acute myocardial infarction. Circulation, 1993,88:82-91.
  • 3Dicstein K. Natriuretic peptides in detection of heart failure. Lancet, 1998,35: 3-4.
  • 4Clerico A, Iervasi G, Chicca M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998,21: 170-179.
  • 5Maisel A. B-type natriuretic levels: a potential novel "White count" for congestive heart failure. J Cardiac Fail, 2001, 7: 183-193.
  • 6Brandt RR, Burnett Jr. Humoral control of the kidney during congestive heart failure: role of cardiac natriuretic peptides and angiotensin II. In: Poole-Wilson PA, Colucci WS, Massie BM, eds. Heart Failure. New York: Churchill Livingstone, 1997.143-154.
  • 7Mair J, Hammerer-lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med, 2001, 39:571-588.
  • 8Talwar S, Squire IB, Downie PF, et al. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart, 2000,84:421-424.
  • 9Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92:1558-1564.
  • 10Maisel AS, Krishnaswamy P, Nowak RM,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347:161.

共引文献59

同被引文献58

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部